James C. Czirr, Director at GALECTIN THERAPEUTICS INC (GALT), sold 91,907 shares at $5.12 ($471K) on 2018-06-01, disclosed to the SEC on 2018-06-05.
Open-market sale of $471k GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.12 | 41,907 | $215K | 45.6% |
| 2 | $5.12 | 41,907 | $215K | 45.6% |
| 3 | $5.13 | 8,093 | $42K | 8.8% |
| Total | $5.12 avg | 91,907 | $471K | 100% |
| Filing → |
| GALT | SELL | 2022-08-09 | $21K | — | Filing → |
| GALT | SELL | 2021-08-03 | $33K | — | Filing → |
| GALT | SELL | 2021-05-04 | $109K | — | Filing → |